Annual meeting with partners

Carbon Dioxide Activation Center

Carbon Dioxide Activation Center is a Centre of excellence established on April 1st 2015. CADIAC is based on funding from the Danish National Research Foundation. Research within CADIAC focuses on the conversion of CO2 to valuable chemical compounds, and it is developed in collaboration with a growing number of partners across and outside Europe.

News from CADIAC

2017.10.06 | CADIAC, iNano

PhD Study in Synthetic Organic Chemistry

If you are interested in joining a dynamic research group in synthetic organic chemistry, then there are two available PhD stipends in the Skrydstrup group. Our research is focused on the development of new synthetic methodology using transition metal catalysis. This includes methodology for accessing pharmaceutically relevant molecules, isotope…

2017.01.25 | CADIAC

CADIAC publishes on Videnskab.dk

http://videnskab.dk/naturvidenskab/co2-kan-blive-fremtidens-ressource

Events & Meetings in CADIAC

No articles found in this list

News from iNano

(Ill: Henning Larsen Architects)

2018.07.06 | iNano

Aarhus University selected as the first Danish ‘lighthouse’ research environment in Lund

Denmark has invested billions of DKK in state-of-the-art research facilities around the European Spallation Source (ESS) near Lund in Sweden. Bo Brummerstedt will now be the first research director of a Danish lighthouse environment that will work towards realising the ambitions behind the huge Danish investment. The appointment is accompanied by…

Schematic representation of the albumin molecule engaging with the neonatal FcRn receptor. Graphics supplied by Albumedix Ltd.

2018.06.29 | iNano

New cancer target identified for albumin enabled anti-cancer therapeutics

Researchers from the NanoPharmaceutical Lab at the Interdisciplinary Nanoscience Center (iNANO) Aarhus University led by Associate Professor Ken Howard, together with researchers from Albumedix Ltd., have identified a novel target in several cancer types that may pave the way for efficient delivery of drugs into cancer cells using the blood…